http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2545191-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5d22cd3a9bdbfb599f2e51e61ace09d |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2011-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c14dc25a520d8fb4c07c1c5bea74395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e89da239770b6da01fef783fd73adef0 |
publicationDate | 2013-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2545191-A2 |
titleOfInvention | Mrna as biomarkers for liver injury or other liver perturbations |
abstract | The present invention provides a method for assessing the likelihood or for detecting the presence of liver perturbation in an individual. The method is particularly useful for detecting drug-induced liver injury (DILI) or other forms of hepatotoxicity or hepatic perturbation. The method comprises measuring the level of at least one RNA biomarker comprising mRNA and comparing the measured level to an appropriate reference value for the sample type and RNA biomarker type, and wherein a significant difference between the measured level and the reference value is indicative of liver perturbation. |
priorityDate | 2010-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 755.